Related Experiment Video
Updated: Aug 10, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
H Fontaine1, B Nalpas, B Poulet
1Unité d'Hépatologie and INSERM U370, Hôpital Necker, Paris, France.
Insights
Chronic hepatitis C progression is slow in most patients, with only 20% worsening. High necroinflammatory activity is a key predictor of liver fibrosis progression in hepatitis C virus (HCV) infection.
Area of Science:
- Hepatology
- Virology
- Pathology
Background:
- Chronic hepatitis C virus (HCV) infection is a significant global health concern.
- Understanding the natural history and spontaneous progression of HCV is crucial for patient management.
- Histopathologic assessment of liver biopsies is a standard method for evaluating liver disease severity.
Purpose of the Study:
- To analyze the spontaneous histopathologic progression of chronic hepatitis C in untreated patients.
- To identify factors associated with disease worsening, particularly fibrosis progression.
- To evaluate the utility of necroinflammatory activity as a predictor for fibrosis progression.
Main Methods:
- Analysis of sequential liver biopsies using Metavir and Knodell scoring systems in untreated HCV patients.
- Assessment of changes in necroinflammatory activity and fibrosis over time.
- Multivariate analysis to determine predictors of fibrosis progression.
Main Results:
- Similar results were observed using both Metavir and Knodell scores.
- At baseline, most patients had low activity (78.9%) and fibrosis (82.9%).
- Disease activity increased in 18.5% of patients, with higher rates in genotype 1 infections.
- Fibrosis progression was significantly associated with higher initial necroinflammatory activity (P <.01).
- High activity score was a significant predictor of fibrosis progression (RR, 25.5; P =.004).
Conclusions:
- Spontaneous worsening of chronic hepatitis C occurs in a minority of patients (around 20%).
- Necroinflammatory activity is a critical factor driving liver fibrosis progression.
- Histopathologic activity should be considered a major clue in therapeutic decision-making for chronic hepatitis C.
Abstract:
To analyze the spontaneous pathologic progression of chronic hepatitis C, we analyzed the histopathologic semiquantitative scores (Metavir and Knodell) of sequential liver biopsies performed in untreated hepatitis C virus (HCV)-infected patients. Subjects included 35 men and 41 women, with a mean age of 41 +/- 12 years, a duration of HCV infection of 11 +/- 5 years, and an interval between liver biopsies of 3.7 +/- 2.5 years. Results obtained using the Knodell score and the Metavir score were similar. At the first biopsy, 78.9% of patients had a low activity score (A0-A1) and 82.9% had a low fibrosis score (F0-F2). At the second biopsy, the activity decreased in 9.2%, was unchanged in 72.4%, and increased in 18.5%. An increase in activity was more frequently observed in patients infected with genotype 1 (28.9%) than with others (7.7%; P =.04); the yearly progression of activity was significantly higher in patients with a low rather than high initial activity score (0.11 v -0.02; P <.01). An increase in fibrosis was noted in 13.3% of those with a low and 43.8% of those with a high initial activity score (P <.01), with a highest rate of yearly fibrosis progression (0.12 U). In multivariate analysis, only a high activity score was significantly associated with an increased risk of fibrosis progression (relative risk, 25.5; 95% confidence interval, 2.7 to 238; P =.004). Spontaneous chronic hepatitis C evolution is worsening in only 20% of patients. Fibrosis progression is significantly associated with the necroinflammatory activity suggesting that this factor should be regarded as a major clue for deciding therapy.
More Related Videos
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology